Maya ShmulevitzPronouns: she/her

Summary:

The Shmulevitz laboratory explores and applies the non-pathogenic reoviruses towards two health focuses. First, it seeks to better understand the mechanisms of, and improve potency of oncolytic reovirus towards breast cancers. For example, we discover host factors in the breast tumor microenvironment that restrict the direct tumor cell killing and immunotherapeutic activities of reovirus, and re-engineer reovirus to overcome such restrictions. We also discovered many changes to reovirus that improve the infection, dissemination and oncolytic activity of reovirus against breast cancers. Our studies use both cell culture and murine models of breast cancer. Second, we are developing reovirus-based vaccine vectors towards mucosal pathogens.

Stories this researcher is featured in:

July 17, 2026

Warming up the hunt for a cancer cure

By optimizing how cancer-fighting viruses are tested in the lab, Dr. Maya Shmulevitz is turning a century-old medical mystery into a precise, life-saving reality. 

Featuring Maya Shmulevitz Read more